Cancer Research AACR Conference on Molecular Diagnostics - 2008  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 398-407, February 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhuyan, B. K.
Right arrow Articles by Fraser, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhuyan, B. K.
Right arrow Articles by Fraser, T. J.

Cell Cycle Phase Specificity of Antitumor Agents1

B. K. Bhuyan, L. G. Scheidt and T. J. Fraser

Research Laboratories, The Upjohn Company, Kalamazoo, Michigan 49001

The sensitivity to drugs of synchronous and asynchronous populations of DON cells was studied. Agents that were cytotoxic at a specific phase of the cell cycle gave dose-survival curves that decreased to a constant saturation value. DNA synthesis inhibitors such as 1-ß-D-arabinofuranosylcytosine, 5-azacytidine, 5-hydroxy-2-formylpyridinethiosemicarbazone (NSC 107392), sodium camptothecin (NSC 100880), 5-fluorodeoxyuridine, and pseudourea (NSC 56054) were most cytotoxic to cells in the S phase. However, the DNA synthesis inhibitor, neocarzinostatin, was most cytotoxic to cells in the G1 phase. The protein synthesis inhibitors, pactamycin and sparsomycin, were also most cytotoxic to cells in the S phase. Cells in the G1-S border region were most sensitive to the RNA synthesis inhibitors, actinomycin D and nogalamycin, and to the alkylating agents, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Streptozotocin and tubercidin, which markedly inhibit the synthesis of DNA, RNA, and protein, were cytotoxic to cells in all phase of the cell cycle. 5-Fluorouracil was also not phase specific. Cells in mitosis and in the G1 phase were most sensitive to chlorambucil, L-phenylalanine mustard, and ellipticine.

1 This study was supported in part by Contract PH43-68-1023 with Chemotherapy, National Cancer Institute, NIH, Bethesda, Md. 20014.

Received 12/21/70. Accepted 11/ 3/71.




This article has been cited by other articles:


Home page
Cancer Res.Home page
K. Keyes, K. Cox, P. Treadway, L. Mann, C. Shih, M. M. Faul, and B. A. Teicher
An In Vitro Tumor Model: Analysis of Angiogenic Factor Expression after Chemotherapy
Cancer Res., October 1, 2002; 62(19): 5597 - 5602.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.